NeoGenomics Sets $793-801M Revenue Target for 2026 as RaDaR ST and PanTracer Initiatives Gain Popularity

Featured in:
abcd

Call Earnings Statistics: NeoGenomics, Inc. (NEO) Q4 2025

Management view

  • CEO Anthony Zook announced record fourth-quarter 2025 revenues of $190 million, highlighting 11% year-over-year growth and stating, “Our clinical business continued strong growth, with revenues increasing 16% year-over-year.” He attributed the sturdy clinical effect

Alpha Search Disclaimer: This article was automatically generated by an AI tool from content available on Seeking Alpha and has not been curated or reviewed by humans. Due to the inherent limitations in the operate of AI-based tools, the accuracy, completeness or currency of such articles cannot be guaranteed. This article is for informational purposes only. Seeking Alpha does not take your goals or your financial situation into account and does not offer any personalized investment advice. Seeking Alpha is not a licensed U.S. securities dealer, broker-dealer, investment advisor or investment bank.

abcd
sadasda

Find us on

Latest articles

Related articles

See more articles

FedEx Raises FY26 EPS Outlook to $19.30-20.10 on Profitable...

Follow us on Google for the latest stock market newsFollow Seeking Alpha on Google for the latest...

3 things to do now as the annual ISA...

Image source: Getty Images Just over...

Are Barclays shares really 50% cheaper than HSBC right...

Image source: Getty Images Barclays (LSE:BARC)...